|
1
|
Johansson B, Fioretos T and Mitelman F:
Cytogenetic and molecular genetic evolution of chronic myeloid
leukemia. Acta Haematol. 107:76–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shtivelman E, Lifshitz B, Gale RP and
Canaani E: Fused transcript of abl and bcr genes in chronic
myelogenous leukemia. Nature. 315:550–554. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
La Starza R, Testoni N, Lafage-Pochitaloff
M, Ruggeri D, Ottaviani E, Perla G, Martelli MF, Marynen P and
Mecucci C: Complex variant Philadelphia translocations involving
the short arm of chromosome 6 in chronic myeloid leukemia.
Haematologica. 87:143–147. 2002.
|
|
4
|
Todorić-Zivanović B, Marisavljević D,
Surace C, Cemerikić V, Marković O, Krtolica K, Tatomirović Z,
Cikota B, Magić Z and Rocchi M: A Ph-negative chronic myeloid
leukemia with a complex BCR/ABL rearrangement and a
t(6;9)(p21;q34.1). Cancer Genet Cytogenet. 166:180–185.
2006.PubMed/NCBI
|
|
5
|
Naumann S and Decker HJ: Genesis of
variant Philadelphia chromosome translocations in chronic
myelocytic leukemia. Cancer Genet Cytogenet. 147:18–22. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fitzgerald PH and Morris CM: Complex
chromosomal translocations in the Philadelphia chromosome
leukemias. Serial translocations or a concerted genomic
rearrangement? Cancer Genet Cytogenet. 57:143–151. 1991. View Article : Google Scholar
|
|
7
|
Griffen J: The biology of signal
transduction The biology of signal transduction inhibition: basic
science to novel therapies. Semin Oncol. 28:3–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kantarjian H, Sawyers C, Hochhaus A,
Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D,
Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B, Goldman J,
O’Brien SG, Russell N, Fischer T, Ottmann O, Cony-Makhoul P, Facon
T, Stone R, Miller C, Tallman M, Brown R, Schuster M, Loughran T,
Gratwohl A, Mandelli F, Saglio G, Lazzarino M, Russo D, Baccarani M
and Morra E: International STI571 CML Study Group: Hematologic and
cytogenetic responses to imatinib mesylate in chronic myelogenous
leukemia. N Engl J Med. 346:645–652. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cortes JE, Talpaz M, Giles F, O’Brien S,
Rios MB, Shan J, Garcia-Manero G, Faderl S, Thomas DA, Wierda W,
Ferrajoli A, Jeha S and Kantarjian HM: Prognostic significance of
cytogenetic clonal evolution in patients with chronic myelogenous
leukemia on imatinib mesylate therapy. Blood. 101:3794–3800. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shaffer L, Slovak M and Cambell L; ISCN
(2009). An International System for Human Cytogenetic Nomenclature.
S. Karger; Basel: 2009
|
|
12
|
Al-Achkar W, Wafa A and Nweder MS: A
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous
leukemia. J Exp Clin Cancer Res. 26:411–415. 2007.PubMed/NCBI
|
|
13
|
Weise A, Mrasek K, Fickelscher I, Claussen
U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition
of high-resolution multicolor banding probes: first within the
human DNA sequence anchored FISH banding probe set. J Histochem
Cytochem. 56:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liehr T, Heller A, Starke H, Rubtsov N,
Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U:
Microdissection based high resolution multicolor banding for all 24
human chromosomes. Int J Mol Med. 9:335–339. 2002.PubMed/NCBI
|
|
15
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations in Cancer. 2009,
http://cgap.nci.nih.gov/Chromosomes/Mitelman.
|
|
16
|
Nacheva E, Holloway T, Brown K, Bloxham D
and Green AR: Philadelphia-negative chronic myeloid leukaemia:
detection by FISH of BCR-ABL fusion gene localized either to
chromosome 9 or chromosome 22. Br J Haematol. 87:409–412. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reid AG, Huntly BJP, Grace C, Green AR and
Nacheva EP: Survival implications of molecular heterogeneity in
variant Philadelphia-positive chronic myeloid leukaemia. Br J
Haematol. 121:419–427. 2003. View Article : Google Scholar : PubMed/NCBI
|
